MBOT · Microbot Medical Inc.
Market Cap
$99.40M
Shares
67.16M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.49
Open$1.49
Day$1.46–1.50
52W close$1.47–4.50
Avg vol 30d701K
Short int7.2M · 10.7% float · 8.1d
Short vol48%
DataJan 2020–Aug 2026
Filing10-Q · Aug 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−27%
below
Price vs 50-day avg
−14%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−16%
trailing
6-month return
−41%
trailing
YTD return
−26%
this year
Relative strength
−54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-11% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
10.70% of float · ▼ -2.8% MoM · 8.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
−88%
Y/Y
Gross margin
759%
expanding
EPS growth
+60%
Y/Y
Free cash flow
$-13.1M
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
5.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−27%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-11% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
10.70% of float · ▼ -2.8% MoM · 8.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 1%
Range high $5
vs 200-day avg -27%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MBOT
this stock
Microbot Medical Inc.
|
$99.40M | -25.5% | — | — | 10.7% |
|
ABT
Abbott Laboratories
|
$191.81B | -11.9% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -7.9% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$116.78B | -5.6% | +8.4% | 24.5 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.3% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MBOT | +0.7% | -15.8% | -40.9% | -13.4% | -25.5% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | +0.2% | -17.1% | -54.1% | -16.1% | -38.0% |
Key facts
CIK
883975
CUSIP
59503A204
13F (30d)
60 filings
54 filers
Visit website
Investor relations